CLOZAPINE Response in Biotype-1

Clinical trial NCT04580134 · RECRUITING

Trial details

NCT number: NCT04580134
Sponsor: University of Texas Southwestern Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Bipolar 1 Disorder

Start date: 2022-03-01
Primary completion: 2027-04-30
Enrollment: 524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.